The current M&A environment and its strategic implications for emerging biotherapeutics companies

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.16, Iss.2, 2010-04, pp. : 109-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Delivering biotherapeutics – technical opportunities and strategic trends

By Shohet S

Journal of Commercial Biotechnology, Vol. 9, Iss. 1, 2002-09 ,pp. : 59-66

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Biotechnology M&A insight: Deals and strategies

By Pavlou Alex K

Journal of Commercial Biotechnology, Vol. 10, Iss. 1, 2003-09 ,pp. : 85-91

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Marketspace: Trends in biotherapeutics

By Pavlou Alex K

Journal of Commercial Biotechnology, Vol. 9, Iss. 4, 2003-06 ,pp. : 358-363

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Changes to the European Union pharmaceutical legislation: Implications of the ‘Pharma Review’ for biotechnology companies

By Liikanen Erkki

Journal of Commercial Biotechnology, Vol. 11, Iss. 1, 2004-10 ,pp. : 38-43

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Microgravity and its implications for fermentation biotechnology

By Klaus D.M.

Trends in Biotechnology, Vol. 16, Iss. 9, 1998-09 ,pp. : 369-373

Elsevier

Access to resources Recommend Favorite